CytoDyn Inc. SEC filings CYDY
CytoDyn Inc. has 1,001 filings in SEC EDGAR's recent list, going back to Jul 15, 2015. Its latest annual report, Form 10-K, was filed on Aug 31, 2026 for the period ended May 31, 2026. The latest quarterly report (Form 10-Q) was filed on Oct 14, 2026, covering the quarter ended Aug 31, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on May 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Oct 7, 2026 | — |
| EFFECT | Filing | Oct 2, 2026 | — |
| EFFECT | Filing | Oct 2, 2026 | — |
| EFFECT | Filing | May 20, 2026 | — |
| D | Filing | May 11, 2026 | — |
| EFFECT | Filing | Dec 16, 2025 | — |
| EFFECT | Filing | Dec 2, 2025 | — |
| CORRESP | Letter to the SEC | Nov 26, 2025 | — |
| EFFECT | Filing | Aug 21, 2025 | — |
| CORRESP | Letter to the SEC | Aug 19, 2025 | — |
| CORRESP | Letter to the SEC | Aug 18, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 31, 2025 | — |
| EFFECT | Filing | Oct 1, 2024 | — |
| CORRESP | Letter to the SEC | Sep 26, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 17, 2024 | — |
| EFFECT | Filing | Sep 12, 2024 | — |
| EFFECT | Filing | Sep 12, 2024 | — |
| SC TO-I/A | Filing | Jul 22, 2024 | — |
| SC TO-I/A | Filing | Jul 9, 2024 | — |
| CORRESP | Letter to the SEC | Jun 28, 2024 | — |
| SC TO-I/A | Filing | Jun 28, 2024 | — |
| CORRESP | Letter to the SEC | Jun 20, 2024 | — |
| SC TO-I/A | Filing | Jun 20, 2024 | — |
| CORRESP | Letter to the SEC | Jun 12, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 10, 2024 | — |
| SC TO-I | Filing | Jun 3, 2024 | — |
| EFFECT | Filing | Feb 21, 2024 | — |
| CORRESP | Letter to the SEC | Feb 15, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 13, 2024 | — |
| NT 10-Q | Filing | Oct 16, 2023 | Aug 31, 2023 |
| EFFECT | Filing | Oct 5, 2023 | — |
| NT 10-K | Filing | Aug 30, 2023 | May 31, 2023 |
| EFFECT | Filing | Jul 10, 2023 | — |
| CORRESP | Letter to the SEC | Jul 6, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 26, 2023 | — |
| EFFECT | Filing | Feb 9, 2023 | — |
| EFFECT | Filing | Feb 9, 2023 | — |
| EFFECT | Filing | Feb 9, 2023 | — |
| EFFECT | Filing | Feb 9, 2023 | — |
| EFFECT | Filing | Feb 9, 2023 | — |
| EFFECT | Filing | Feb 9, 2023 | — |
| EFFECT | Filing | Feb 9, 2023 | — |
| EFFECT | Filing | Feb 9, 2023 | — |
| EFFECT | Filing | Sep 30, 2022 | — |
| CORRESP | Letter to the SEC | Sep 28, 2022 | — |
| RW | Filing | Sep 26, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 21, 2022 | — |
| D/A | Filing | Sep 19, 2022 | — |
| EFFECT | Filing | Sep 2, 2022 | — |
| CORRESP | Letter to the SEC | Aug 30, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 29, 2022 | — |
| NT 10-K | Filing | Aug 1, 2022 | May 31, 2022 |
| D/A | Filing | Apr 25, 2022 | — |
| D | Filing | Apr 22, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 14, 2021 | — |
| D | Filing | Dec 3, 2021 | — |
| DFAN14A | Filing | Nov 5, 2021 | — |
| DFAN14A | Filing | Oct 26, 2021 | — |
| DFAN14A | Filing | Oct 19, 2021 | — |
| DFAN14A | Filing | Oct 14, 2021 | — |
| DEFC14A | Filing | Oct 14, 2021 | — |
| PRER14A | Filing | Oct 7, 2021 | — |
| EFFECT | Filing | Oct 6, 2021 | — |
| CORRESP | Letter to the SEC | Oct 6, 2021 | — |
| UPLOAD | Letter from the SEC | Oct 6, 2021 | — |
| DFRN14A | Filing | Oct 6, 2021 | — |
| CORRESP | Letter to the SEC | Oct 5, 2021 | — |
| CORRESP | Letter to the SEC | Oct 4, 2021 | — |
| DFAN14A | Filing | Oct 4, 2021 | — |
| DFAN14A | Filing | Sep 30, 2021 | — |
| DFAN14A | Filing | Sep 28, 2021 | — |
| PREC14A | Filing | Sep 24, 2021 | — |
| DFAN14A | Filing | Sep 24, 2021 | — |
| DFAN14A | Filing | Sep 20, 2021 | — |
| DFAN14A | Filing | Sep 20, 2021 | — |
| DFRN14A | Filing | Sep 17, 2021 | — |
| DFAN14A | Filing | Sep 17, 2021 | — |
| D | Filing | Sep 16, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 14, 2021 | — |
| DFAN14A | Filing | Sep 7, 2021 | — |
| DFAN14A | Filing | Sep 2, 2021 | — |
| DFAN14A | Filing | Sep 2, 2021 | — |
| DFAN14A | Filing | Aug 31, 2021 | — |
| DFAN14A | Filing | Aug 31, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 31, 2021 | — |
| DFAN14A | Filing | Aug 31, 2021 | — |
| DFAN14A | Filing | Aug 26, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 24, 2021 | — |
| DFAN14A | Filing | Aug 19, 2021 | — |
| DFAN14A | Filing | Aug 18, 2021 | — |
| DEFC14A | Filing | Aug 18, 2021 | — |
| DFAN14A | Filing | Aug 17, 2021 | — |
| DFAN14A | Filing | Aug 13, 2021 | — |
| PRRN14A | Filing | Aug 13, 2021 | — |
| DFAN14A | Filing | Aug 12, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 3, 2021 | — |
| DFAN14A | Filing | Aug 2, 2021 | — |
| PREC14A | Filing | Jul 20, 2021 | — |
| DFAN14A | Filing | Jul 7, 2021 | — |
| DFAN14A | Filing | Jul 1, 2021 | — |
| UPLOAD | Letter from the SEC | Jun 8, 2021 | — |
| CORRESP | Letter to the SEC | May 24, 2021 | — |
| UPLOAD | Letter from the SEC | May 24, 2021 | — |
| CORRESP | Letter to the SEC | May 21, 2021 | — |
| UPLOAD | Letter from the SEC | May 19, 2021 | — |
| CORRESP | Letter to the SEC | May 7, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 16, 2021 | — |
| CORRESP | Letter to the SEC | Mar 23, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 18, 2021 | — |
| EFFECT | Filing | Jan 22, 2021 | — |
| CORRESP | Letter to the SEC | Jan 21, 2021 | — |
| UPLOAD | Letter from the SEC | Jan 21, 2021 | — |
| EFFECT | Filing | Dec 30, 2020 | — |
| CORRESP | Letter to the SEC | Dec 29, 2020 | — |
| UPLOAD | Letter from the SEC | Dec 29, 2020 | — |
| D | Filing | Dec 16, 2020 | — |
| D | Filing | Dec 16, 2020 | — |
| EFFECT | Filing | Sep 25, 2020 | — |
| CORRESP | Letter to the SEC | Sep 23, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 23, 2020 | — |
| PRER14A | Filing | Jun 8, 2020 | — |
| EFFECT | Filing | May 11, 2020 | — |
| CORRESP | Letter to the SEC | May 6, 2020 | — |
| D/A | Filing | Apr 7, 2020 | — |
| D | Filing | Mar 30, 2020 | — |
| SEC STAFF LETTER | Filing | Mar 2, 2020 | — |
| D | Filing | Feb 14, 2020 | — |
| SEC STAFF LETTER | Filing | Feb 10, 2020 | — |
| UPLOAD | Letter from the SEC | Feb 4, 2020 | — |
| D/A | Filing | Nov 12, 2019 | — |
| EFFECT | Filing | Sep 30, 2019 | — |
| CORRESP | Letter to the SEC | Sep 27, 2019 | — |
| CORRESP | Letter to the SEC | Sep 26, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 26, 2019 | — |
| CORRESP | Letter to the SEC | Sep 24, 2019 | — |
| UPLOAD | Letter from the SEC | Sep 13, 2019 | — |
| SC TO-I/A | Filing | Aug 2, 2019 | — |
| SC TO-I/A | Filing | Jul 26, 2019 | — |
| SC TO-I/A | Filing | Jul 25, 2019 | — |
| SC TO-I/A | Filing | Jul 19, 2019 | — |
| SC TO-I | Filing | Jun 24, 2019 | — |
| SC TO-I/A | Filing | Jun 17, 2019 | — |
| SC TO-I/A | Filing | May 22, 2019 | — |
| SC TO-I | Filing | May 14, 2019 | — |
| D | Filing | Apr 2, 2019 | — |
| EFFECT | Filing | Feb 14, 2019 | — |
| CORRESP | Letter to the SEC | Feb 13, 2019 | — |
| UPLOAD | Letter from the SEC | Feb 5, 2019 | — |
| 15-12G | Deregistration | Dec 3, 2018 | — |
| EFFECT | Filing | Nov 28, 2018 | — |
| EFFECT | Filing | Nov 28, 2018 | — |
| EFFECT | Filing | Nov 28, 2018 | — |
| 8-K12G3 | Filing | Nov 19, 2018 | Nov 16, 2018 |
| 425 | 8-k | Nov 5, 2018 | — |
| UPLOAD | Letter from the SEC | Oct 11, 2018 | — |
| UPLOAD | Letter from the SEC | Oct 5, 2018 | — |
| CORRESP | Letter to the SEC | Sep 24, 2018 | — |
| UPLOAD | Letter from the SEC | Sep 17, 2018 | — |
| D | Filing | Sep 10, 2018 | — |
| 425 | Form 8-k/a | Aug 31, 2018 | — |
| UPLOAD | Letter from the SEC | May 8, 2018 | — |
| PRER14A | Amended preliminary proxy statement | May 4, 2018 | — |
| UPLOAD | Letter from the SEC | Mar 30, 2018 | — |
| SC TO-I/A | Filing | Mar 26, 2018 | — |
| EFFECT | Filing | Mar 23, 2018 | — |
| CORRESP | Letter to the SEC | Mar 21, 2018 | — |
| SC TO-I/A | Filing | Mar 20, 2018 | — |
| UPLOAD | Letter from the SEC | Mar 19, 2018 | — |
| SC TO-I/A | Filing | Mar 14, 2018 | — |
| EFFECT | Filing | Mar 7, 2018 | — |
| CORRESP | Letter to the SEC | Mar 5, 2018 | — |
| UPLOAD | Letter from the SEC | Mar 2, 2018 | — |
| SC TO-I/A | Filing | Feb 28, 2018 | — |
| D/A | Filing | Feb 28, 2018 | — |
| SC TO-I/A | Filing | Feb 20, 2018 | — |
| SC TO-I/A | Filing | Feb 20, 2018 | — |
| SC TO-I/A | Filing | Feb 14, 2018 | — |
| CORRESP | Letter to the SEC | Feb 13, 2018 | — |
| SC TO-I/A | Filing | Feb 7, 2018 | — |
| UPLOAD | Letter from the SEC | Feb 6, 2018 | — |
| SC TO-I/A | Filing | Jan 31, 2018 | — |
| SC TO-I/A | Filing | Jan 25, 2018 | — |
| SC TO-I/A | Filing | Jan 23, 2018 | — |
| SC TO-I/A | Filing | Jan 10, 2018 | — |
| SC TO-I/A | Sc to-i/a (amendment no. 7) | Jan 8, 2018 | — |
| SC TO-I/A | Sc to-i/a (amendment no. 6) | Dec 29, 2017 | — |
| SC TO-I/A | Filing | Dec 21, 2017 | — |
| SC TO-I/A | Filing | Dec 15, 2017 | — |
| CORRESP | Letter to the SEC | Dec 13, 2017 | — |
| SC TO-I/A | Filing | Dec 7, 2017 | — |
| SC TO-I/A | Filing | Dec 6, 2017 | — |
| SC TO-I/A | Filing | Nov 27, 2017 | — |
| SC TO-I | Filing | Nov 24, 2017 | — |
| D | Filing | Nov 16, 2017 | — |
| D | Filing | Jun 14, 2017 | — |
| CT ORDER | Filing | Apr 24, 2017 | — |
| EFFECT | Filing | Oct 21, 2016 | — |
| CORRESP | Letter to the SEC | Oct 19, 2016 | — |
| UPLOAD | Letter from the SEC | Oct 11, 2016 | — |
| EFFECT | Filing | Sep 9, 2016 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CYDY (OTC)
- Fiscal year ends
- May 31
- Incorporated in
- DE
- Headquarters
- Vancouver, WA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1175680
- Former names
- CYTODYN INC (until Apr 13, 2016); REXRAY CORP (until Nov 12, 2003)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.